To Radiate or Not to Radiate? Updates to Management of Retroperitoneal Sarcoma
Retroperitoneal sarcomas (RPS), a rare subset of soft tissue sarcomas, account for 10-15% of these cases and are distinguished by their substantial size, infiltrative nature, and proximity to vital anatomical structures.
Category
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiation as an Immune Catalyst: Techniques, Biology and Biomaterials for Enhancing Tumor Control
Increasing evidence has demonstrated the importance of immunomodulation on tumor control. Radiotherapy, specifically, can produce a multitude of local and systemic immunomodulatory effects, including reprogramming the tumor microenvironment and exposing tumor antigens via in situ vaccination.
Category
  • Immunotherapy
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Reirradiation with Stereotactic Body Radiation Therapy for Spinal Metastases: Planning Procedure from a High-Volume Multi-Disciplinary Spine Oncology Program (SOaR2)
This journal activity provides practitioners with the knowledge needed to identify indications and technical details of reirradiation of metastatic disease of the spine.This activity is available from May 6, 2026, through 11:59 p.m. Eastern time on May 5, 2028.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
ASTRO/KCA Joint Activity: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate
This activity brings together an international panel and multidisciplinary expertise to discuss the emerging role of SABR to the primary in renal cell carcinoma (RCC).
Category
  • SBRT
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
A Systematic Review of Patient-Reported Outcomes on the Impact of Radiotherapy on Sexual Health in Gynecologic Cancer Patients
This education activity reviews the evidence on the impact of radiotherapy on sexual health in patients with gynecological malignancies, using a systematic review methodology. This activity describes sexual dysfunction prevalence and severity, trajectories, and contributing factors.
Category
  • Gynecologic
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Introductory Physics Modules
This course is designed to provide introductory physics videos and materials for radiation oncology residents. 
Category
  • Physics
Format
Credits
  • 1.00 Certificate of Attendance
Cost $0.00
Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
Patient reported outcomes (PROs) are a key component of evaluating cancer therapy. For clinical trialists, the proper design, implementation and evaluation of patient reported outcomes is critical for designing studies that will impact and inform daily practice.
Category
  • Professional Development
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Contemporary Multi-Disciplinary Management of Bladder Cancer
The management of bladder cancer is evolving across the spectrum of disease and stage and this educational activity is extremely valuable to the ASTRO membership.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
ASTRO/ILROG Joint Activity: The Comeback of RT – Radiation Therapy is Back in the Frontline of Managing Hodgkin and Indolent Lymphomas
Given the rarity of lymphomas, many clinicians are not using radiation therapy appropriately in the frontline setting.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
The Fast CAR Race: Where Does Radiotherapy Place? Challenging Cases in the Cellular Therapy Era
This activity includes four challenging cases in lymphoma and myeloma with a panel of expert radiation oncologists, including one in private practice, and a medical oncologist. 1. Urgent need for debulking in extramedullary relapse of multiple myeloma after BCMA-targeted CAR T-cell therapy.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages